| 000 | 01826 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514160303.0 | ||
| 264 | 0 | _c20031031 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0014-4886 | ||
| 024 | 7 |
_a10.1016/s0014-4886(03)00213-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGalanopoulou, Aristea S | |
| 245 | 0 | 0 |
_aSex-specific KCC2 expression and GABA(A) receptor function in rat substantia nigra. _h[electronic resource] |
| 260 |
_bExperimental neurology _cOct 2003 |
||
| 300 |
_a628-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channels, L-Type _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGABA Agonists _xpharmacology |
| 650 | 0 | 4 | _aGABA-A Receptor Agonists |
| 650 | 0 | 4 |
_aGene Expression Regulation, Developmental _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscimol _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNifedipine _xpharmacology |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xmetabolism |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aSubstantia Nigra _xcytology |
| 650 | 0 | 4 |
_aSymporters _xgenetics |
| 650 | 0 | 4 | _aK Cl- Cotransporters |
| 700 | 1 | _aKyrozis, Andreas | |
| 700 | 1 | _aClaudio, Olga I | |
| 700 | 1 | _aStanton, Patric K | |
| 700 | 1 | _aMoshé, Solomon L | |
| 773 | 0 |
_tExperimental neurology _gvol. 183 _gno. 2 _gp. 628-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-4886(03)00213-9 _zAvailable from publisher's website |
| 999 |
_c14298148 _d14298148 |
||